论文部分内容阅读
氨酰心安(Atenolol)是一种不具有内源拟交感活性的心脏选择性β-肾上腺素能受体阻滞剂。1972年英国开始应用于临床。我院自1980年8月应用天津市中央制药厂生产的氨酰心安治疗高血压、心律失常与心绞痛患者共110例。初步总结如下:
Atenolol is a cardioselective β-adrenergic receptor blocker that does not possess endogenous sympathomimetic activity. Britain began to apply in clinical in 1972. Our hospital since August 1980 Tianjin Central Pharmaceutical Factory production of atenolol treatment of hypertension, arrhythmia and angina patients a total of 110 cases. Preliminary summary is as follows: